Researchers have identified a new subtype of prostate cancer that occurs in about 7 percent of patients with advanced disease. This subset of tumors were responsive to immunotherapy treatment.
Researchers have identified a new subtype of prostate cancer that occurs in about 7 percent of patients with advanced disease. This subset of tumors were responsive to immunotherapy treatment.